Understanding and Managing Pregnancy in Patients with Lupus
Open Access
- 12 July 2015
- journal article
- review article
- Published by Hindawi Limited in Autoimmune Diseases
- Vol. 2015, 1-18
Abstract
Systemic lupus erythematosus (SLE) is a chronic, multisystemic autoimmune disease that occurs predominantly in women of fertile age. The association of SLE and pregnancy, mainly with active disease and especially with nephritis, has poorer pregnancy outcomes, with increased frequency of preeclampsia, fetal loss, prematurity, growth restriction, and newborns small for gestational age. Therefore, SLE pregnancies are considered high risk condition, should be monitored frequently during pregnancy and delivery should occur in a controlled setting. Pregnancy induces dramatic immune and neuroendocrine changes in the maternal body in order to protect the fetus from immunologic attack and these modifications can be affected by SLE. The risk of flares depends on the level of maternal disease activity in the 6–12 months before conception and is higher in women with repeated flares before conception, in those who discontinue useful medications and in women with active glomerulonephritis at conception. It is a challenge to differentiate lupus nephritis from preeclampsia and, in this context, the angiogenic and antiangiogenic cytokines are promising. Prenatal care of pregnant patients with SLE requires close collaboration between rheumatologist and obstetrician. Planning pregnancy is essential to increase the probability of successful pregnancies.Keywords
This publication has 129 references indexed in Scilit:
- American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritisArthritis Care & Research, 2012
- Association of the idiotype:antiidiotype antibody ratio with the efficacy of intravenous immunoglobulin treatment for the prevention of recurrent autoimmune‐associated congenital heart blockArthritis & Rheumatism, 2011
- Contraceptive counseling and use among women with systemic lupus erythematosus: A gap in health care quality?Arthritis Care & Research, 2010
- Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open‐label clinical trialArthritis & Rheumatism, 2010
- Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart blockArthritis & Rheumatism, 2010
- Prospective Evaluation of Fetuses With Autoimmune-Associated Congenital Heart Block Followed in the PR Interval and Dexamethasone Evaluation (PRIDE) StudyThe American Journal of Cardiology, 2009
- A national study of the complications of lupus in pregnancyAmerican Journal of Obstetrics and Gynecology, 2008
- A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virusAmerican Journal of Obstetrics and Gynecology, 2007
- Lupus Activity in PregnancyRheumatic Disease Clinics of North America, 2007
- TH-17 cells in the circle of immunity and autoimmunityNature Immunology, 2007